Basic information
- CAS
33369-31-2- Standard SMILES
Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1- InChIKey
ZXVNMYWKKDOREA-UHFFFAOYSA-N- Molecular formula
- C15H14ClNO3
- Average molar mass
- 291.73 g/mol
- Monoisotopic mass
- 291.06622099
Overview
Zomepirac is a monocarboxylic acid, a member of pyrroles, an aromatic ketone and a member of monochlorobenzenes. It has a role as a non-steroidal anti-inflammatory drug and a cardiovascular drug. It is functionally related to an acetic acid.
Names & identifiers
- Preferred name
- Zomepirac
- IUPAC
- 2-[5-(4-chlorobenzoyl)-1,4-dimethylpyrrol-2-yl]acetic acid
- English name
- zomepirac
- Molecular formula
- C15H14ClNO3
- Molecular weight
- 291.73
Names & synonyms
Show more names
Database identifiers
- CAS
33369-31-2、64092-49-5- PubChem CID
- 5733
- DTXSID
DTXSID9023754- ChEMBL
CHEMBL19490- ChEBI
CHEBI:35859- UNII
- 822G987U9J
- EC Number
- 251-474-2
- Nikkaji
- J21.385C
Properties
Computed structural properties
- XLogP
- 2.8
- Topological polar surface area
- 59.3 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 3
- Rotatable bonds
- 4
- Heavy atoms
- 20
- Formal charge
- 0
- Complexity
- 379
Experimental & physicochemical properties
Physicochemical properties
- Melting point
- 178 · 178-179°
- Boiling point
- 470.8 · 470.8±45.0 °C(Predicted)
- Density
- 1.28 · 1.28±0.1 g/cm3(Predicted)
- solubility
- Methanol (Sparingly), Water (Slightly)
- pka
- 4.57 · pKa 4.57(H2O-EtOH (1:1 v/v)) (Uncertain)
- form
- Solid
- color
- Off-White to Yellow
- Stability
- Hygroscopic
- FDA UNII
- 822 G987U9J · 822G987U9J
- ATC code
- 1 AB04 · M01AB04
Safety & regulation
Hazard information
Toxicology
Drug Induced Liver Injury
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
zomepirac
DILI Negative
DOI:10.1016/j.drudis.2019.09.022
Chemistry & industry
Pharmacology
ATC Code
M - Musculo-skeletal system
QM - Musculo-skeletal system
MeSH Pharmacological Classification
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Uses & manufacturing
Applications
UsesZomepirac is an analgesic, anti-inflammatory drug.
Upstream & downstream products
Upstream raw materials
Suppliers5 total
Additional notes
DefinitionChEBI: Zomepirac is a member of pyrroles, a member of monochlorobenzenes, a monocarboxylic acid and an aromatic ketone. It has a role as a non-steroidal anti-inflammatory drug and a cardiovascular drug. It is functionally related to an acetic acid.
Related reactions
Compound notes
Loading…